facebook-page-view
Advertisement

Biocon subsidiary Syngene International looking to raise over $50M

By Jasleen Kaur Batra

  • 19 Aug 2014
Premium
Biocon subsidiary Syngene International looking to raise over $50M

Syngene International, a subsidiary of Biocon Ltd, a generics major that also owns the country's largest drug research and development services unit, is looking to raise over $50 million, at least two sources privy to the matter told VCCircle.  "This is more like a pre-IPO round," said one of the ......

This is a Premium article. Please subscribe or log in to read the full story!

Here's a selection of our recent premium content.

Already a member? Click here to log in.
Advertisement
Advertisement